gene_id,uniprot_accession.x,gene_name.x,Entry.Name.x,Protein.names.x,Gene.Names.x,Gene.Ontology.biological.process.x,Gene.Ontology.IDs.x,PSC.56,PSC.52,PSC.54,PSC.61,PSC.64,PSC.73,PSC.76,PSC.81,PSC.59,PSC.57,PSC.69,PSC.67,PSC.71,PSC.75,PSC.78,PSC.83,PSC.0228,PSC.0187,PSC.0188,PSC.0174,PSC.0190,PSC.0231,PSC.0230,PSC.0219,PSC.0177,PSC.0186,PSC.0209,PSC.0203
g15976,Q92542,NICA_HUMAN,NICA_HUMAN,Nicastrin,NCSTN KIAA0253 UNQ1874/PRO4317,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0010950; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926,1653,2990,4337,3815,4876,4572,3651,3757,3401,4839,2439,3672,3711,3295,1552,6571,3299,2106,1812,3291,2703,2322,2400,1582,2115,1814,1612,1524
g19177,P48052,CBPA2_HUMAN,CBPA2_HUMAN,Carboxypeptidase A2 (EC 3.4.17.15),CPA2,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270,1313,12,8,15,7,1588,8,60,3178,39,45,648,171,569,525,8084,601,7678,34428,102,274,40983,57,476,1915,190,1063,901
g19176,P00730,CBPA1_BOVIN,CBPA1_BOVIN,Carboxypeptidase A1 (EC 3.4.17.1),CPA1 CPA,leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508],GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270,402,8,0,0,8,347,0,33,1433,23,15,288,31,95,88,3223,218,1949,6377,19,164,17052,19,96,454,120,382,231
g2736,Q5I0D7,PEPD_RAT,PEPD_RAT,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),Pepd,collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009,5317,6171,6926,6289,12052,10701,6966,9130,10953,6033,17155,11340,8655,1697,4217,4381,2738,3493,4338,2702,1292,2562,9741,10021,7300,4272,10045,5334
g13145,P08594,AQL1_THEAQ,AQL1_THEAQ,Aqualysin-1 (EC 3.4.21.111) (Aqualysin-I),pstI,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508,293,265,249,525,273,592,525,626,40,50,35,25,37,0,25,18,21,53,8,21,30,14,307,246,170,287,420,162
g11371,Q9QX15,CA3A1_MOUSE,CA3A1_MOUSE,Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-),Clca3a1 Clca1,chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0046872,50,51,77,0,11,160,505,54,444,698,4506,1945,1695,467,545,1925,1494,572,854,719,288,203,190,48,33,42,11,310
g11370,Q9D7Z6,CLCA1_MOUSE,CLCA1_MOUSE,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 3) (mCLCA3) (Protein gob-5),Clca1 Clca3 Gob5,calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0006821; GO:0008237; GO:0016020; GO:0030141; GO:0042589; GO:0046872; GO:0071456,4,15,5,0,3,28,71,8,36,84,677,409,283,75,146,357,287,86,234,121,55,36,55,4,14,9,0,37
g21051,Q96LD8,SENP8_HUMAN,SENP8_HUMAN,"Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)",SENP8 DEN1 NEDP1 PRSC2 FKSG8,post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0000338; GO:0005829; GO:0006508; GO:0008234; GO:0016579; GO:0019784; GO:0043687,776,1061,1227,1131,1148,1585,1055,1629,311,170,389,347,293,44,424,95,51,97,78,83,12,57,427,402,225,594,195,341
g17554,Q6ICB0,DESI1_HUMAN,DESI1_HUMAN,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1),DESI1 FAM152B PPPDE2,protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; protein modification by small protein removal [GO:0070646]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676; GO:0070646,887,1093,1078,655,1546,887,921,1305,1230,604,1077,1482,1522,102,885,935,1485,1339,709,375,294,833,558,425,385,379,482,441
g18353,O02467,ASPG_SPOFR,ASPG_SPOFR,N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],,proteolysis [GO:0006508],GO:0003948; GO:0004067; GO:0005764; GO:0006508; GO:0008798,505,616,716,528,612,706,741,799,242,139,206,293,387,64,486,249,117,150,237,168,61,109,447,410,310,444,464,446
g21154,A6QR55,UBP4_BOVIN,UBP4_BOVIN,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4),USP4,negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244],GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0016579; GO:0031397; GO:0031647; GO:0034394; GO:0046872; GO:1904263,814,690,1091,962,1157,1145,606,725,2175,3848,684,2596,2219,1259,735,4089,2618,1106,1712,1508,2601,2089,798,370,707,491,597,536
g21155,B2GUZ1,UBP4_RAT,UBP4_RAT,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4),Usp4,negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244],GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872; GO:1904263,671,558,1036,920,928,1213,601,673,2146,3716,878,2452,2191,1985,702,4060,2805,1163,1756,1495,2763,2235,831,513,698,440,455,645
g11915,A0A2S3R7M0,MARTX_VIBVL,MARTX_VIBVL,Multifunctional-autoprocessing repeats-in-toxin (MARTX) (EC 3.4.22.-) [Cleaved into: Actin cross-linking toxin F1 (EC 6.3.2.-); N-epsilon-fatty acyltransferase F2 (EC 2.3.1.-) (Rho inactivation domain-containing toxin F2) (RIDvc); ABH effector region toxin F5; Cysteine protease domain-containing toxin F3 (EC 3.4.22.-)],CRN52_02910,proteolysis [GO:0006508],GO:0005576; GO:0006508; GO:0008234; GO:0008289; GO:0016020; GO:0016746; GO:0016874; GO:0020002; GO:0044164; GO:0046872; GO:0090729,152,57,55,6,189,199,288,96,295,165,3697,1011,5220,72,306,645,2599,13744,2725,67,21,2357,168,455,170,49,61,322
g5810,Q9CXT6,KDM8_MOUSE,KDM8_MOUSE,Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8) (Lysine-specific demethylase 8),Kdm8 Jmjd5,circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796,439,789,784,771,665,929,924,1263,118,59,116,201,91,14,69,64,77,140,73,97,61,54,410,360,168,367,321,250
g15068,Q15485,FCN2_HUMAN,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,244,570,368,449,44,20,207,309,5,0,12,9,0,4,4,19,19,23,5,10,8,14,118,22,17,247,0,123
g1332,P47245,NRDC_RAT,NRDC_RAT,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Nrdc Nrd1,negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0120163,257,388,259,273,326,240,435,448,180,66,160,261,104,24,142,42,93,115,62,61,8,26,185,143,130,172,174,135
g23743,P55866,CASP3_XENLA,CASP3_XENLA,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (xCPP32) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],casp3,proteolysis [GO:0006508],GO:0004175; GO:0005737; GO:0006508; GO:0097200,1680,2577,3036,2396,3597,3283,2459,3089,2120,2408,1758,2450,2603,3185,1188,6069,2549,1912,1911,4182,2804,2474,1483,1415,1408,1559,1345,1383
g9438,Q9UDY8,MALT1_HUMAN,MALT1_HUMAN,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),MALT1 MLT,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321,2733,4683,5763,5713,7187,4662,6832,6041,7350,12060,11754,10803,13648,8149,3781,14688,11852,9398,6462,6437,12090,8725,3191,3026,3246,2646,3190,2066
g16352,Q8IYS1,P20D2_HUMAN,P20D2_HUMAN,Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase),PM20D2 ACY1L2,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246,41,40,59,12,31,190,778,14,417,750,584,5993,1734,24,1130,332,228,747,363,72,11,259,53,19,0,27,37,225
g7863,O43895,XPP2_HUMAN,XPP2_HUMAN,Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2),XPNPEP2,proteolysis [GO:0006508],GO:0004177; GO:0005576; GO:0005886; GO:0006508; GO:0016020; GO:0046872; GO:0070006; GO:0070062; GO:0098552,146,14,14,5,0,246,11,24,476,0,25,52,0,89,50,1599,81,633,2188,0,21,1938,12,85,371,29,88,90
g22278,P37892,CBPE_LOPAM,CBPE_LOPAM,Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),cpe,proteolysis [GO:0006508],GO:0004181; GO:0005576; GO:0006508; GO:0008270; GO:0030658,577,424,404,350,512,589,537,354,376,224,486,1045,803,113,450,425,657,1563,692,202,106,663,285,315,202,245,164,209
g2743,Q54P70,Y4757_DICDI,Y4757_DICDI,OTU domain-containing protein DDB_G0284757 (EC 3.1.2.-),DDB_G0284757,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0016579,303,458,348,291,252,331,366,632,174,24,40,133,37,0,811,13,17,18,32,33,4,19,309,237,179,234,142,140
g23157,P80646,CTRB_GADMO,CTRB_GADMO,Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B],,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586,281,152,222,352,306,314,560,357,1209,968,827,3313,1340,337,789,1472,4066,13090,2993,155,1185,3017,311,145,122,260,103,303
g588,P80146,SEPR_THESR,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508,754,22,32,22,40,836,17,63,1058,33,64,343,133,289,729,2681,391,1791,10373,44,128,19193,17,150,413,56,315,340
g21213,Q5G266,NETR_TRAPH,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195,181,25,42,31,244,582,28,32,1445,764,1257,780,689,568,356,3096,2413,10420,4700,69,865,11456,41,369,372,99,546,296
g21210,G5ECS8,ADT1_CAEEL,ADT1_CAEEL,A disintegrin and metalloproteinase with thrombospondin motifs adt-1 (ADAMTS adt-1) (EC 3.4.24.-),adt-1 C02B4.1,extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872,100,55,73,18,89,109,86,93,12180,8087,6485,9024,7006,8997,2510,15046,8741,8039,3917,572,19647,14783,97,87,14,21,207,79
g4026,Q9VT65,CANB_DROME,CANB_DROME,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],CalpB CG8107,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,4687,12603,10277,11987,9851,16089,12420,12431,1761,983,1172,3254,2062,318,3788,1370,837,1274,2321,536,561,1302,12906,12040,6745,6784,11178,7537
g13110,P17538,CTRB1_HUMAN,CTRB1_HUMAN,Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C],CTRB1 CTRB,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586,149,15,13,24,13,69,51,75,515,204,830,977,1588,132,63,294,1869,3701,265,29,391,308,16,647,25,11,73,18
g23741,Q9CXY9,GPI8_MOUSE,GPI8_MOUSE,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),Pigk,attachment of GPI anchor to protein [GO:0016255]; proteolysis [GO:0006508],GO:0003923; GO:0006508; GO:0016255; GO:0042765,423,376,303,315,339,293,483,400,121,52,105,146,90,10,212,80,96,102,144,86,18,36,266,166,139,207,192,237
g6550,A3KQS4,MINY1_DANRE,MINY1_DANRE,Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A),mindy1 fam63a si:ch211-210h11.5,proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0036435; GO:1990380,279,179,178,246,205,203,239,259,339,294,195,606,426,111,263,409,374,292,297,166,265,178,220,137,86,140,87,185
g3583,Q7L266,ASGL1_HUMAN,ASGL1_HUMAN,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],ASRGL1 ALP CRASH,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],GO:0001917; GO:0004067; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008798; GO:0033345,837,969,603,504,466,487,508,903,568,42,64,364,212,22,1790,50,42,12,44,26,7,28,198,205,79,149,227,243
g5241,Q95M12,LGMN_BOVIN,LGMN_BOVIN,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)",LGMN PRSC1,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185,490,3,4,4,7,779,0,33,1409,28,37,77,33,168,117,5120,565,1693,6375,11,86,5743,12,217,962,27,423,273
g8177,Q9DEX3,CATD_CLUHA,CATD_CLUHA,Cathepsin D (EC 3.4.23.5),ctsd,proteolysis [GO:0006508],GO:0004190; GO:0005764; GO:0006508,3398,6016,6654,4080,6561,6625,5743,7243,7733,5890,7118,6188,7042,2185,4510,7612,4780,4250,6166,4374,1542,3804,4456,2418,3188,2221,3839,2207
g6127,P20825,POL2_DROME,POL2_DROME,Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575,22,177,71,168,46,130,226,184,26,0,40,5,12,4,0,0,0,9,48,0,9,6,115,66,76,118,74,42
g19768,P87362,BLMH_CHICK,BLMH_CHICK,Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40) (Aminopeptidase H),BLMH,homocysteine catabolic process [GO:0043418]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636],GO:0004177; GO:0004197; GO:0005737; GO:0006508; GO:0008234; GO:0009636; GO:0043418; GO:0070005,392,249,463,432,465,339,315,321,363,439,203,538,432,102,341,390,359,233,225,327,131,213,410,184,162,147,191,143
g24087,P12821,ACE_HUMAN,ACE_HUMAN,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]",ACE DCP DCP1,amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310],GO:0001666; GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0007565; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0019229; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0032496; GO:0032943; GO:0034616; GO:0038166; GO:0042310; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0060978; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0086091; GO:0090281; GO:0097066; GO:0097225; GO:0097746; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170,26,382,0,0,13,225,67,254,395,75,68,494,190,15,1679,448,138,814,701,11,0,1014,14,51,89,9,50,89
g4204,Q9Y3Q0,NALD2_HUMAN,NALD2_HUMAN,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),NAALAD2,proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872,19,12,6,0,7,124,194,9,206,81,54,593,133,7,159,544,85,200,796,5,12,828,13,10,170,8,0,63
g623,O00602,FCN1_HUMAN,FCN1_HUMAN,Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin),FCN1 FCNM,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370,1689,5044,5317,492,965,1094,1938,2999,186,82,101,80,16,61,53,152,38,10,10,88,45,51,117,243,44,964,635,463
g19175,P15088,CBPA3_HUMAN,CBPA3_HUMAN,Mast cell carboxypeptidase A (MC-CPA) (EC 3.4.17.1) (Carboxypeptidase A3),CPA3,proteolysis [GO:0006508]; regulation of angiotensin levels in blood [GO:0002002],GO:0002002; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0030133; GO:0030141; GO:0062023,49,0,0,0,2,50,0,7,189,2,0,48,2,35,29,507,85,371,1095,0,41,2613,0,17,62,10,131,65
g9657,A0A386CAB9,NLRP1_DANRE,NLRP1_DANRE,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",nlrp1 si:ch211-66k16.28,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558,515,1429,2202,1258,1112,1326,1612,1692,1359,3509,869,1153,1304,3653,361,3499,1308,525,444,1395,2540,1360,588,580,387,468,1137,403
g18370,B5DEQ3,XPP3_RAT,XPP3_RAT,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Xpnpep3,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,249,235,216,174,303,256,261,228,109,28,123,185,100,21,715,31,45,28,25,61,7,6,178,150,122,152,233,119
g18371,Q9NQH7,XPP3_HUMAN,XPP3_HUMAN,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),XPNPEP3,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,514,336,328,305,478,343,368,466,200,59,121,371,123,17,1139,60,26,51,35,66,20,32,143,181,115,197,93,144
g3861,P00767,CTRB_BOVIN,CTRB_BOVIN,Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C],,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586,1284,15,15,13,32,2088,10,63,4652,27,32,724,152,428,542,8094,809,11392,51277,65,346,60116,73,608,2336,317,975,816
g18940,P04323,POL3_DROME,POL3_DROME,Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575,55,24,161,158,31,59,137,282,0,6,0,11,0,0,0,10,7,4,10,0,0,0,198,3,103,66,29,224
g22159,Q99PW6,MMP24_RAT,MMP24_RAT,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],Mmp24 Mt5mmp,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008233; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742,3446,1270,6522,906,5100,6626,2081,9707,21615,150062,4638,15113,5476,53506,6667,76250,9537,4856,10730,15497,25305,36431,5790,3341,2823,855,524,1856
g21444,Q9P2N4,ATS9_HUMAN,ATS9_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),ADAMTS9 KIAA1312,aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192],GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671,291,469,384,1140,427,70,1580,1217,120,22,376,161,120,20,82,101,33,43,171,6,32,145,487,394,211,169,260,320
g17386,P23004,QCR2_BOVIN,QCR2_BOVIN,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",UQCRC2,proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0005743; GO:0006508; GO:0046872; GO:0070469,7898,2830,2771,2029,3825,2889,2717,3042,4325,5386,1552,7237,5737,2374,1862,3658,2712,976,1247,2188,2265,1763,1460,1252,1323,1010,1185,894
g8609,P59509,ATS19_MOUSE,ATS19_MOUSE,A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-),Adamts19,aortic valve morphogenesis [GO:0003180]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0003180; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0030199; GO:0031012; GO:0046872,486,74,80,150,138,120,6,85,186,130,482,286,322,816,120,1247,282,267,281,1693,806,176,154,95,66,8,287,50
g619,P21128,ENDOU_HUMAN,ENDOU_HUMAN,Uridylate-specific endoribonuclease (EC 4.6.1.-) (Placental protein 11) (PP11) (Protein endoU),ENDOU,female pregnancy [GO:0007565]; immune response [GO:0006955]; negative regulation of lipid catabolic process [GO:0050995]; post-transcriptional gene silencing [GO:0016441]; proteolysis [GO:0006508],GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0006955; GO:0007565; GO:0008083; GO:0008236; GO:0016441; GO:0016829; GO:0030145; GO:0030247; GO:0050995,71,0,0,2,0,72,4,7,122,9,0,69,41,7,97,418,107,844,3751,14,43,2912,0,9,198,12,0,49
g6237,Q1JPJ2,XPP1_BOVIN,XPP1_BOVIN,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",XPNPEP1,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006,1254,1034,1091,1558,1141,1192,1787,1228,966,867,1283,2061,1494,329,1074,1689,1088,3108,1723,445,381,1723,894,665,486,566,892,723
g6234,F1NV61,CASP7_CHICK,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686,0,172,8,5,7,98,133,134,312,298,305,3597,804,11,1818,230,105,266,70,10,0,116,35,14,7,9,14,51
g1564,P69527,AMPO_RAT,AMPO_RAT,Aminopeptidase O (AP-O) (EC 3.4.11.-),Aopep Onpep,proteolysis [GO:0006508],GO:0005730; GO:0006508; GO:0008270; GO:0070006,829,697,836,835,562,585,923,869,91,52,34,318,323,17,136,65,46,76,87,65,16,9,551,357,219,430,315,320
g21824,A8K7I4,CLCA1_HUMAN,CLCA1_HUMAN,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1),CLCA1 CACC1,calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508],GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005902; GO:0006508; GO:0006816; GO:0034220; GO:0042589; GO:0046872; GO:0071456,239,0,15,0,11,941,54,16,3126,35,180,329,105,147,373,5168,939,5499,6318,25,95,10422,64,385,685,44,574,606
g21822,Q6Q473,CLA4A_MOUSE,CLA4A_MOUSE,"Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form]",Clca4a Clca6,chloride transport [GO:0006821]; proteolysis [GO:0006508],GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872,28,8,0,0,0,70,3,0,308,0,12,45,42,15,28,790,97,322,821,17,0,1485,0,84,44,12,0,38
g3194,P16444,DPEP1_HUMAN,DPEP1_HUMAN,Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP),DPEP1 MDP RDP,antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; lactam catabolic process [GO:0072340]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508],GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006749; GO:0006751; GO:0006954; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031528; GO:0034235; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071466; GO:0071732; GO:0072340; GO:0072341; GO:0098552; GO:1901749,2215,4762,7450,10209,4739,8682,5334,7745,228,178,856,349,351,77,210,400,125,123,780,501,85,1003,5178,3467,1884,3451,1457,2401
g3207,Q9NQC7,CYLD_HUMAN,CYLD_HUMAN,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),CYLD CYLD1 KIAA0849 HSPC057,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein localization [GO:1903829]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; Wnt signaling pathway [GO:0016055]",GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0032088; GO:0032480; GO:0035872; GO:0036064; GO:0043369; GO:0045087; GO:0045577; GO:0045582; GO:0046329; GO:0048471; GO:0048872; GO:0050727; GO:0050728; GO:0050862; GO:0060544; GO:0061578; GO:0061815; GO:0070064; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1901223; GO:1902017; GO:1903753; GO:1903829; GO:1990108; GO:1990380; GO:2000493; GO:2001238; GO:2001242,1126,1644,1923,1709,2033,1617,2006,2441,4620,8561,1758,6758,4039,2801,1837,6616,6655,3128,3519,2373,6734,5693,1856,1217,1197,2233,1400,1732
g12673,Q3ULA2,FBW1A_MOUSE,FBW1A_MOUSE,F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit),Btrc Fbw1 Fbxw1 Fwd1 Kiaa4123,branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-templated transcription [GO:0045892]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0008013; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1990756; GO:1990757,899,650,615,486,700,934,768,916,1580,1593,768,2666,2020,729,601,3096,1297,1731,1745,1625,1963,1889,695,407,489,513,209,466
g1917,Q9UKP5,ATS6_HUMAN,ATS6_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),ADAMTS6,aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976,803,2497,1993,5533,945,5915,6737,5645,656,494,573,1663,881,198,607,584,428,284,438,91,461,108,4358,2333,1483,4341,3303,2843
g11906,Q99497,PARK7_HUMAN,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,"activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of supramolecular fiber organization [GO:1902903]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]",GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006508; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007265; GO:0007338; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060765; GO:0061691; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901671; GO:1901984; GO:1902176; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903376; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1903751; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000379; GO:2000679; GO:2000825; GO:2001237; GO:2001268,936,745,692,620,1152,902,619,875,332,113,209,395,192,28,518,184,176,226,193,96,128,176,521,365,407,308,503,337
g9401,O76031,CLPX_HUMAN,CLPX_HUMAN,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",CLPX,ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662,574,359,490,176,255,283,258,377,331,380,471,394,887,113,176,245,206,197,307,189,90,223,208,216,154,192,184,161
g21415,Q9UQC9,CLCA2_HUMAN,CLCA2_HUMAN,"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]",CLCA2 CACC3,cell adhesion [GO:0007155]; monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508],GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006508; GO:0007155; GO:0009925; GO:0030054; GO:0031965; GO:0034220; GO:0046872; GO:0070161,3945,11786,8957,10014,7382,8539,14529,11950,2728,1813,2433,1960,4872,837,464,2442,2069,571,794,908,1430,2228,5061,4061,3437,6253,4828,4406
g21414,P54281,CLCA1_BOVIN,CLCA1_BOVIN,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel) (Epithelial chloride channel protein),,calcium ion transport [GO:0006816]; proteolysis [GO:0006508],GO:0005229; GO:0005886; GO:0006508; GO:0006816; GO:0008237; GO:0016324; GO:0046872,10921,33577,22330,25207,22944,21277,41995,30902,6995,5367,4485,5196,12206,1665,1353,6063,4973,1287,2565,1893,3972,5986,14282,10769,9425,16701,14321,11912
g3728,Q6GQ29,CBPQ_XENLA,CBPQ_XENLA,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),cpq pgcp,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573,2727,5343,5742,4454,4504,4680,4729,5448,1471,499,803,1636,1606,222,3872,827,396,731,1120,375,209,952,2777,2214,2065,2493,2230,2102
g5188,Q4R7U8,ASGL1_MACFA,ASGL1_MACFA,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],ASRGL1 QtsA-14329,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,871,1160,1231,806,828,1390,881,860,237,73,237,316,480,24,348,75,70,123,67,102,31,42,522,497,434,110,369,501
g1331,Q8BHG1,NRDC_MOUSE,NRDC_MOUSE,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Nrdc Nrd1,negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508],GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0120163,498,567,466,308,499,399,689,817,263,67,151,388,229,33,236,71,89,113,119,122,32,57,197,153,216,295,236,166
g16353,A3KG59,P20D2_MOUSE,P20D2_MOUSE,Xaa-Arg dipeptidase (EC 3.4.13.4),Pm20d2 Acy1l2 Gm424,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246,692,1317,1555,1015,878,1166,1210,1238,399,126,226,423,150,16,202,122,137,157,241,162,46,107,741,529,280,555,269,492
g20362,O57382,TLL2_XENLA,TLL2_XENLA,Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid),tll2 xld,cell differentiation [GO:0030154]; proteolysis [GO:0006508],GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154,54,347,448,102,62,106,189,263,23,20,13,0,24,0,0,17,27,12,6,0,18,9,138,66,53,77,559,23
g19004,Q9Y5R2,MMP24_HUMAN,MMP24_HUMAN,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],MMP24 MT5MMP,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742,106,81,113,42,378,99,78,47,2075,798,311,1762,842,287,387,1018,1716,333,983,121,662,1858,132,83,346,20,55,63
g19379,P20918,PLMN_MOUSE,PLMN_MOUSE,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Plg,"biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0007596; GO:0009897; GO:0009986; GO:0010812; GO:0016525; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0062023; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1990405,24,36,0,0,0,13,0,17,38,17,201,34,346,401,178,1135,198,164,57,130,357,35,0,5,0,0,0,11
g9283,P16519,NEC2_HUMAN,NEC2_HUMAN,Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2),PCSK2 NEC2,enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0030425; GO:0034230; GO:0034231; GO:0043005; GO:0043204; GO:0043231,177,219,217,137,291,149,233,164,637,796,222,555,688,568,383,2074,1363,380,299,589,1502,613,133,100,129,79,87,96
g17596,B1AQJ2,UBP36_MOUSE,UBP36_MOUSE,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Usp36 Kiaa1453,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],GO:0003723; GO:0004843; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0042981; GO:0050821; GO:0140936; GO:1990380; GO:2000232,816,867,882,1019,1015,857,953,2146,2603,1011,665,1269,1135,454,4657,1038,870,584,554,557,1033,561,721,551,524,611,449,653
g14832,Q5G266,NETR_TRAPH,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195,169,176,156,81,128,120,203,185,22,44,34,49,47,16,50,0,20,41,13,16,10,0,58,49,55,141,114,35
g23767,Q2T9J0,TYSD1_HUMAN,TYSD1_HUMAN,"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form]",TYSND1,protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998],GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0016020; GO:0016485; GO:0031998; GO:0042802,347,391,466,187,241,336,301,495,86,22,49,106,94,11,97,19,11,41,104,25,7,33,250,249,48,332,54,106
g11276,Q8TE57,ATS16_HUMAN,ATS16_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),ADAMTS16 KIAA2029,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,920,615,740,702,761,560,499,441,194246,246523,87870,143134,76643,72086,33818,89400,84772,23520,42462,642,98361,192556,620,338,148,97,507,550
g11277,P25723,TLD_DROME,TLD_DROME,Dorsal-ventral patterning protein tolloid (EC 3.4.24.-),tld CG6868,"amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]",GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030513; GO:0032927; GO:0045464,388,100,204,185,198,186,215,141,61248,69969,36758,42693,22321,25894,10214,24614,28686,8547,13491,240,31993,61959,155,106,53,24,138,183
g11275,Q8TE57,ATS16_HUMAN,ATS16_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),ADAMTS16 KIAA2029,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,308,212,237,217,240,158,141,161,67078,76324,19207,50948,20255,16062,10200,28961,20229,6253,12362,204,23139,54671,175,95,42,25,110,132
g16700,Q9R0S2,MMP24_MOUSE,MMP24_MOUSE,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],Mmp24 Mmp21 Mt5mmp,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742,2451,5547,18088,9082,4574,7786,7810,5367,1126,1107,102,285,1739,496,195,1043,900,101,296,269,544,143,3769,2607,2511,2837,4716,6095
g7450,Q15485,FCN2_HUMAN,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,1627,4927,551,273,3282,15464,5046,2141,1364,44737,17103,32638,34169,9643,1486,46115,45479,4626,2011,12639,6304,42963,2706,5110,1409,1028,1253,159
g2495,P55112,NAS4_CAEEL,NAS4_CAEEL,Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4),nas-4 C05D11.6,proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270,5,0,0,0,0,0,0,4,353,239,203,62,108,75,19,325,286,315,217,20,551,71,5,7,0,0,0,4
g2494,P55115,NAS15_CAEEL,NAS15_CAEEL,Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15),nas-15 T04G9.2,proteolysis [GO:0006508],GO:0004222; GO:0005576; GO:0006508; GO:0008270,3804,9715,14031,19038,5008,15806,21451,16552,2598,643,1620,1065,1579,517,710,787,1265,297,832,224,832,44,7738,2978,6440,10328,5461,10375
g11751,P49275,DERF3_DERFA,DERF3_DERFA,Mite allergen Der f 3 (EC 3.4.21.-) (Allergen Der f III) (allergen Der f 3),DERF3,proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508,4247,35,41,19,56,5660,60,202,8397,118,164,2035,563,1656,1772,25898,1560,18770,61533,125,1090,121843,177,1152,5348,870,4565,2580
g19541,Q9ULZ9,MMP17_HUMAN,MMP17_HUMAN,Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP),MMP17 MT4MMP,collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0070006; GO:0098552,265,627,723,447,1330,1129,534,544,10287,15158,2447,10259,8579,6364,3890,12649,12536,4402,3601,1620,15936,7807,627,381,599,545,1524,834
g19543,Q99542,MMP19_HUMAN,MMP19_HUMAN,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),MMP19 MMP18 RASI,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0001525; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012,0,3,0,8,0,0,0,0,0,7,12,6,22,9,28,29,11,19,8,0,10,0,0,0,0,0,0,0
g11953,A0A0R4IB93,UBP48_DANRE,UBP48_DANRE,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48),usp48,cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:1904888,965,1350,1516,1060,826,919,1123,1329,338,194,385,705,606,66,291,192,212,200,134,225,73,137,656,589,435,587,340,407
g11952,Q86UV5,UBP48_HUMAN,UBP48_HUMAN,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48),USP48 USP31,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005929; GO:0006508; GO:0016579; GO:0101005,540,550,671,503,327,452,555,607,164,145,261,393,413,68,145,92,79,86,130,74,37,42,250,336,163,246,239,190
g5273,B2RYG6,OTUB1_RAT,OTUB1_RAT,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1),Otub1,adaptive immune response [GO:0002250]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508],GO:0002250; GO:0004843; GO:0005737; GO:0006281; GO:0006508; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0055105; GO:0071108; GO:0071347; GO:1904263; GO:2000780,587,652,639,521,529,630,520,681,170,143,182,303,498,26,365,68,137,251,177,44,34,93,569,415,272,433,282,299
g1360,B6MUN4,MYSM1_BRAFL,MYSM1_BRAFL,"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)",MYSM1 BRAFLDRAFT_86936,chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508],GO:0003677; GO:0003713; GO:0005634; GO:0006338; GO:0006508; GO:0042393; GO:0045944; GO:0046872; GO:0140492; GO:0140950,846,547,604,509,633,441,424,713,130,58,211,584,322,16,119,93,114,102,150,41,32,64,447,315,164,384,321,189
g20679,P13676,ACPH_RAT,ACPH_RAT,Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase),Apeh,amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],GO:0004252; GO:0005737; GO:0006508; GO:0008242; GO:0042802; GO:0050435,1120,1151,1348,1016,943,973,1087,1281,280,167,286,678,468,69,599,215,161,219,237,98,70,188,1036,731,511,702,506,548
g3140,P10619,PPGB_HUMAN,PPGB_HUMAN,Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain],CTSA PPGB,intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647],GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0070062; GO:1904714; GO:1904715,1479,2209,2790,1773,1738,2230,2161,2541,2720,2569,1429,2360,2377,485,1185,2552,1864,1169,1559,855,700,1142,1548,1130,806,917,478,811
g22762,A0A182C2Z2,OVCH_HALRO,OVCH_HALRO,Ovochymase (HrOVCH) (EC 3.4.21.-),OVCH,acrosome reaction [GO:0007340]; fertilization [GO:0009566]; oogenesis [GO:0048477]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007340; GO:0009566; GO:0048477,514,774,775,506,1154,1354,760,500,1274,3141,494,2237,453,283,395,993,2122,1070,799,143,1110,959,616,470,625,513,84,348
g23544,Q8R4K8,PAPP1_MOUSE,PAPP1_MOUSE,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Pappa,cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354],GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0030163; GO:0032354; GO:0046872; GO:0071548,219,55,7,0,0,0,11,9,289,176,100,92,1690,38,45,950,275,225,33,27,98,480,120,0,3,66,0,0
g21781,Q6TH47,STBPA_DANRE,STBPA_DANRE,STAM-binding protein-like A (EC 3.4.19.-),stambpa amsh stambp,protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],GO:0005768; GO:0006508; GO:0032154; GO:0046872; GO:0061578; GO:0070536; GO:0140492,1379,1814,2042,1718,1595,1997,1975,1855,2766,2770,1725,3605,2858,688,913,2262,2248,3163,1732,743,1252,1271,1229,648,886,887,689,795
g15116,O57579,AMPN_CHICK,AMPN_CHICK,Aminopeptidase Ey (EC 3.4.11.20) (Aminopeptidase N),ANPEP APDE,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006,72,14,34,9,7,175,173,4,239,17,412,349,245,50,67,828,135,424,1239,17,8,1471,112,27,133,34,66,156
g15115,P15145,AMPN_PIG,AMPN_PIG,Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13),ANPEP,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0001525; GO:0001618; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008270; GO:0030154; GO:0042277; GO:0043171; GO:0070006,28,15,10,6,5,128,334,0,288,25,329,278,275,14,92,784,194,415,1213,41,12,1239,71,26,179,12,31,166
g22787,Q8NF86,PRS33_HUMAN,PRS33_HUMAN,Serine protease 33 (EC 3.4.21.-) (Serine protease EOS),PRSS33,protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528,274,207,1294,2727,481,567,1949,1241,33,13,0,34,36,24,160,14,35,74,12,8,0,8,1002,665,1030,415,0,814
g19847,O77656,MMP13_BOVIN,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349,1374,631,1038,1293,1494,580,787,554,316366,596004,59596,283612,154913,81885,40975,134022,153892,14989,57560,854,113118,462346,1071,427,130,83,502,859
g3626,Q86V25,VASH2_HUMAN,VASH2_HUMAN,Tubulinyl-Tyr carboxypeptidase 2 (EC 3.4.17.17) (Vasohibin-2) (Vasohibin-like protein),VASH2 VASHL,axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768],GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0106423; GO:0140253,832,28,27,23,15,56,153,46,41,62,47,742,1362,30,51,64,84,353,96,24,0,185,69,48,12,44,29,36
g19283,Q8I7P9,POL5_DROME,POL5_DROME,Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],pol,DNA integration [GO:0015074]; DNA transposition [GO:0006313]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0006508; GO:0008233; GO:0015074; GO:0042575,69,126,64,50,71,59,101,51,16,0,10,30,18,0,0,0,11,6,23,12,0,3,39,53,9,67,66,36
g852,P90850,YCF2E_CAEEL,YCF2E_CAEEL,Uncharacterized peptidase C1-like protein F26E4.3,F26E4.3,proteolysis [GO:0006508],GO:0005615; GO:0006508; GO:0008234,2911,3953,3156,2214,15096,6450,3615,3180,12874,63184,3197,21648,17320,20781,6227,26655,37616,2844,4966,16899,39870,33146,2927,5924,10253,1018,10363,3542
g21351,P53634,CATC_HUMAN,CATC_HUMAN,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],CTSC CPPI,immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235,1972,4311,3572,3633,4477,4401,4558,4822,4212,5166,2989,4851,3441,1532,1316,5962,4578,2988,5133,3544,1490,1933,4680,2784,3006,2518,3028,2424
g4297,P80146,SEPR_THESR,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508,3918,23,54,68,64,5609,72,184,11438,103,71,1858,509,1626,1266,21398,1303,16600,65815,102,958,91683,177,980,3525,788,5197,2450
g22664,P48147,PPCE_HUMAN,PPCE_HUMAN,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),PREP PEP,proteolysis [GO:0006508],GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012,681,788,812,491,1075,638,633,1120,1545,917,799,1433,1478,337,906,785,735,594,597,609,288,360,502,377,584,300,389,378
g14920,P0CT40,TF29_SCHPO,TF29_SCHPO,Transposon Tf2-9 polyprotein (Retrotransposable element Tf2 155 kDa protein),Tf2-9 SPBC9B6.02c,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508],GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0015074; GO:0046872,8,32,19,42,30,27,43,49,18,0,5,6,4,4,3,0,3,0,8,5,0,0,10,27,17,40,29,10
g1886,Q3UVK0,ERMP1_MOUSE,ERMP1_MOUSE,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Ermp1 D19Wsu12e Fxna Kiaa1815,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508],GO:0001541; GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872,1958,4261,4366,4314,3457,2660,5005,4431,361,417,278,1554,385,64,514,276,405,524,668,308,198,330,4938,1841,2537,2434,1638,1659
g1147,Q8C1A5,THOP1_MOUSE,THOP1_MOUSE,Thimet oligopeptidase (EC 3.4.24.15),Thop1,intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872,889,1258,371,590,517,273,434,589,1065,1368,921,1641,1906,354,3361,837,1479,789,813,450,296,395,420,218,281,202,112,282
g22260,P04813,CTR2_CANLF,CTR2_CANLF,Chymotrypsinogen 2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin 2 chain A; Chymotrypsin 2 chain B; Chymotrypsin 2 chain C],CTRB1 CTRB,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586,3265,3209,5268,4572,6790,4967,5709,4396,21908,6607,13484,10672,44497,30578,3710,55443,52047,15092,8110,1534,39414,13551,4977,4646,1588,3642,9007,1688
g6596,Q8CF97,VCIP1_RAT,VCIP1_RAT,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Vcpip1 Vcip135,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634,798,754,806,776,904,803,1007,1067,654,1084,388,1304,962,552,500,1388,934,640,609,731,1024,896,776,576,383,669,566,497
g19685,Q99542,MMP19_HUMAN,MMP19_HUMAN,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),MMP19 MMP18 RASI,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0001525; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012,9,206,26,0,0,78,269,66,152,191,1773,1416,627,58,962,502,477,188,631,13,4,96,64,0,24,11,26,150
g782,P17945,HGF_RAT,HGF_RAT,Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain],Hgf,animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; proteolysis [GO:0006508]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; skeletal muscle cell proliferation [GO:0014856],GO:0000902; GO:0001889; GO:0001934; GO:0005102; GO:0005615; GO:0006508; GO:0008083; GO:0008284; GO:0014856; GO:0030335; GO:0031100; GO:0031643; GO:0032715; GO:0032733; GO:0033137; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043410; GO:0044877; GO:0045766; GO:0048012; GO:0050673; GO:0050728; GO:0051450; GO:0051897; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:2000573,7,4,7,9,0,28,0,0,21,36,166,0,0,10,66,0,2438,9116,21,0,18,9,0,220,23,11,0,0
g6415,P70627,FOLH1_RAT,FOLH1_RAT,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Folh1 Naalad1,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,311,269,176,160,261,287,917,330,492,460,4405,1636,14826,196,444,576,1669,2983,485,52,59,1189,292,137,147,47,170,289
g18232,Q9JLG8,CAN15_MOUSE,CAN15_MOUSE,Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog),Capn15 Solh,proteolysis [GO:0006508],GO:0004198; GO:0005737; GO:0006508; GO:0046872,221,295,348,317,385,350,288,591,1013,888,336,1435,493,202,113,668,457,411,356,180,602,1248,313,149,116,150,345,200
g12190,P56399,UBP5_MOUSE,UBP5_MOUSE,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),Usp5 Isot,negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation protein catabolic process at presynapse [GO:0140251],GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0098793; GO:0140251; GO:2000059,1891,1521,1413,1164,1806,1227,1388,1545,1458,1216,998,2207,2081,348,947,1385,1155,1206,704,1410,687,642,920,780,1016,562,947,600
g13659,Q5XJY4,PARL_MOUSE,PARL_MOUSE,"Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",Parl Psarl,membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mitophagy [GO:1901524]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465],GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006465; GO:0006508; GO:0008053; GO:0016485; GO:0030162; GO:0033619; GO:0090201; GO:1901524; GO:1903214; GO:2000377; GO:2001243,267,123,124,86,165,116,136,134,124,100,44,238,169,237,151,688,183,122,98,266,134,82,118,102,69,107,74,37
g10615,Q19AZ8,THRB_PIG,THRB_PIG,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],F2,acute-phase response [GO:0006953]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; proteolysis [GO:0006508],GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0030168; GO:0030194; GO:0062023,1193,2028,2295,1793,1490,1853,1814,2287,237,317,533,704,484,119,300,426,229,287,341,374,216,350,957,598,624,1176,724,805
g17537,F1NV61,CASP7_CHICK,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686,66,17,32,21,114,744,64,55,4833,4832,12509,5305,7950,2757,1783,9548,5559,11793,5636,626,4794,9398,36,134,79,29,425,71
g12017,P20231,TRYB2_HUMAN,TRYB2_HUMAN,Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II),TPSB2 TPS2,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0062023,3656,23,36,37,54,4846,34,126,8978,92,227,1710,594,1261,1325,23275,2238,24753,96413,154,811,110037,110,1338,5929,863,4671,2138
g13001,Q61824,ADA12_MOUSE,ADA12_MOUSE,Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha),Adam12 Mltna,cell adhesion [GO:0007155]; proteolysis [GO:0006508],GO:0004222; GO:0005654; GO:0005886; GO:0006508; GO:0007155; GO:0017124; GO:0046872,2003,3844,3748,3715,7585,5384,3916,5767,23734,35160,8311,18222,12553,5604,3617,14682,14436,5083,9601,3610,13412,19361,3171,2173,4080,1829,4104,2240
g16695,O77656,MMP13_BOVIN,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349,3950,1253,2141,2128,4234,4849,2528,2142,755107,723419,497272,396114,480680,324584,92264,494313,443511,191989,129620,24617,371299,512007,1950,1135,4183,786,1985,3026
g16696,O77656,MMP13_BOVIN,MMP13_BOVIN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),MMP13,bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508],GO:0004175; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0060349,13992,3730,10913,14349,35131,31824,13712,9010,281805,300726,112720,110814,125065,179942,41056,309407,236222,60456,63442,67813,295566,273567,40045,37723,30964,39713,48471,49917
g16692,O35548,MMP16_RAT,MMP16_RAT,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),Mmp16,bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to odorant [GO:1990834]; skeletal system development [GO:0001501],GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094; GO:1990834,274,275,264,171,429,697,954,831,2458,2897,171,1583,956,1032,233,1077,575,149,371,218,894,2231,402,611,291,174,200,395
g21915,Q8BL06,UBP54_MOUSE,UBP54_MOUSE,Ubiquitin carboxyl-terminal hydrolase 54 (EC 3.4.19.12) (Ubiquitin-specific peptidase 54),Usp54,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],GO:0004843; GO:0006508; GO:0016579,1180,953,1018,1118,868,1125,1308,1343,787,1030,1096,1766,1611,569,752,2304,758,861,611,321,741,668,556,391,410,621,334,515
g2193,P80146,SEPR_THESR,SEPR_THESR,Extracellular serine proteinase (EC 3.4.21.-),,proteolysis [GO:0006508],GO:0004252; GO:0005615; GO:0006508,419,59,10,11,8,642,28,76,1067,13,14,193,54,165,157,2869,220,1632,9889,8,79,8597,0,122,651,54,363,267
g22259,P80646,CTRB_GADMO,CTRB_GADMO,Chymotrypsin B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B],,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004252; GO:0005576; GO:0006508; GO:0007586,7,66,32,0,23,28,19,21,672,209,390,610,3502,82,274,298,5931,1478,301,10,214,265,141,34,5,11,0,7
g3166,Q5G266,NETR_TRAPH,NETR_TRAPH,Neurotrypsin (EC 3.4.21.-) (Serine protease 12),PRSS12,exocytosis [GO:0006887]; proteolysis [GO:0006508],GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195,318,202,367,526,299,411,263,645,59,33,29,102,73,14,42,31,70,13,40,17,9,28,396,387,293,339,228,158
g16613,O05218,YWRD_BACSU,YWRD_BACSU,Glutathione hydrolase-like YwrD proenzyme (EC 2.3.2.2) (Putative gamma-glutamyltransferase YwrD) (EC 3.4.19.13) [Cleaved into: Glutathione hydrolase-like YwrD large chain; Glutathione hydrolase-like YwrD small chain],ywrD BSU36100,glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508],GO:0006508; GO:0006751; GO:0036374; GO:0103068,934,2087,1929,1350,729,1376,1916,1411,118,59,116,532,202,23,331,68,18,93,42,44,18,23,772,717,316,641,615,342
g24127,P37892,CBPE_LOPAM,CBPE_LOPAM,Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),cpe,proteolysis [GO:0006508],GO:0004181; GO:0005576; GO:0006508; GO:0008270; GO:0030658,30,38,87,13,32,24,158,27,697,299,291,368,543,1220,149,2331,1731,203,241,37,457,394,50,32,29,17,55,140
g21337,P19221,THRB_MOUSE,THRB_MOUSE,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],F2 Cf2,acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; thrombin-activated receptor signaling pathway [GO:0070493],GO:0001530; GO:0001934; GO:0004175; GO:0004252; GO:0005102; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0008201; GO:0008233; GO:0008284; GO:0008360; GO:0009897; GO:0010468; GO:0030168; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0061844; GO:0062023; GO:0070053; GO:0070493; GO:0070945; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379,120,144,183,54,214,339,257,213,8557,7949,663,11675,5777,4174,2156,12029,19133,3976,5142,1233,9901,15463,225,100,165,86,70,213
g10298,Q15485,FCN2_HUMAN,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),FCN2 FCNL,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,3,0,3,3,6,0,0,0,176,416,224,141,221,238,49,231,390,122,77,144,137,207,6,0,9,0,0,0
g14507,Q9JJ22,ERAP1_RAT,ERAP1_RAT,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP),Erap1 Appils Arts1,adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],GO:0002250; GO:0004175; GO:0004177; GO:0005138; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0016020; GO:0019882; GO:0030163; GO:0042277; GO:0043171; GO:0045766; GO:0070006,738,990,1372,1534,979,891,1350,1537,175,276,420,1003,412,70,417,175,199,338,246,295,98,101,704,615,427,790,876,545
g5494,P15684,AMPN_RAT,AMPN_RAT,Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13),Anpep,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485]; proteolysis [GO:0006508],GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0008270; GO:0009897; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237,0,0,0,2,0,7,0,5,16,0,0,26,7,0,26,40,51,44,21,15,2,178,0,13,11,0,0,18
g18939,P10394,POL4_DROME,POL4_DROME,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,DNA integration [GO:0015074]; proteolysis [GO:0006508],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575,53,35,173,186,15,77,188,293,0,16,5,12,0,2,6,10,0,17,0,4,3,3,254,8,136,58,11,269